Retinitis PigmentosaSymptoms, Doctors, Treatments, Advances & More
Retinitis Pigmentosa Overview
Learn About Retinitis Pigmentosa
Retinitis pigmentosa is an eye disease in which there is damage to the retina. The retina is the layer of tissue at the back of the inner eye. This layer converts light images to nerve signals and sends them to the brain.
RP; Vision loss - RP; Night vision loss - RP; Rod Cone dystrophy; Peripheral vision loss - RP; Night blindness
Common conditions include: X-Linked Retinitis Pigmentosa (XLRP)
Retinitis pigmentosa can run in families. The disorder can be caused by several genetic defects.
The cells controlling night vision (rods) are most likely to be affected. However, in some cases, retinal cone cells are damaged the most. The main sign of the disease is the presence of dark deposits in the retina.
The main risk factor is a family history of retinitis pigmentosa. It is a rare condition affecting about 1 in 4,000 people in the United States and more than 1.5 million people worldwide.
Symptoms often first appear in childhood. However, severe vision problems do not often develop before early adulthood.
- Decreased vision at night or in low light. Early signs may include having a harder time moving around in the dark.
- Loss of side (peripheral) vision, causing "tunnel vision."
- Loss of central vision (in advanced cases). This will affect the ability to read.
- Loss of color vision.
- Sensitivity to bright light.
There is no effective treatment for this condition. Wearing sunglasses to protect the retina from ultraviolet light may help preserve vision.
Some studies suggest that treatment with antioxidants (such as high doses of vitamin A palmitate) may slow the disease. However, taking high doses of vitamin A can cause serious liver problems. The benefit of treatment must be weighed against risks to the liver.
Clinical trials are in progress to assess new treatments for retinitis pigmentosa, including:
- The use of DHA, which is an omega-3 fatty acid.
- The use of supplements containing lutein
- Gene therapy
Other treatments, such as microchip implants into the retina that act like a microscopic video camera, are in the early stages of development. These treatments may be useful for treating blindness associated with RP and other serious eye conditions.
A vision specialist can help you adapt to vision loss. Make regular visits to an eye care specialist, who can detect cataracts or retinal swelling. Both of these problems can be treated.
UNC Kittner Eye Center
Alessandro Iannaccone is an Ophthalmologist practicing medicine in Chapel Hill, North Carolina. Dr. Iannaccone is rated as an Elite provider by MediFind in the treatment of Retinitis Pigmentosa. He is also highly rated in 29 other conditions, according to our data. His clinical expertise encompasses Retinitis Pigmentosa, Retinopathy Pigmentary Mental Retardation, Usher Syndrome Type 2A, and Late-Onset Retinal Degeneration. Dr. Iannaccone is currently accepting new patients.
UPMC Vision Institute
Jose' Sahel is an Ophthalmologist practicing medicine in Pittsburgh, Pennsylvania. Dr. Sahel is rated as an Elite provider by MediFind in the treatment of Retinitis Pigmentosa. He is also highly rated in 34 other conditions, according to our data. His clinical expertise encompasses Retinopathy Pigmentary Mental Retardation, Retinitis Pigmentosa, Cone-Rod Dystrophy, X-Linked Congenital Stationary Night Blindness, and Vitrectomy. Dr. Sahel is currently accepting new patients.
Byron Lam is an Ophthalmologist practicing medicine in Miami, Florida. Dr. Lam is rated as an Elite provider by MediFind in the treatment of Retinitis Pigmentosa. He is also highly rated in 35 other conditions, according to our data. His clinical expertise encompasses X-Linked Retinitis Pigmentosa (XLRP), Retinitis Pigmentosa, Optic Nerve Atrophy, Vitrectomy, and Nerve Decompression. Dr. Lam is currently accepting new patients.
The disorder will continue to progress slowly. Complete blindness is uncommon.
Peripheral and central loss of vision will occur over time.
People with RP often develop cataracts at an early age. They may also develop swelling of the retina (macular edema). Cataracts can be removed if they contribute to vision loss.
Contact your health care provider if you have problems with night vision or you develop other symptoms of this disorder.
Genetic counseling and testing may help determine whether your children are at risk for this disease.
Summary: The Coordination of Rare Diseases at Sanford (CoRDS) is an international patient registry that serves as a centralized resource for rare disease research. Individuals affected by rare diseases, undiagnosed conditions, and disorders of unknown prevalence may voluntarily contribute health information to support natural history studies, participant recruitment, and other research efforts. Through par...
Summary: The goals of this observational study are to develop and train artificial intelligence (AI) algorithms using multimodal imaging to identify patients with inherited retinal degeneration (IRD) caused by Retinal Pigment Epithelium Specific Protein 65 (RPE65) and Retinitis Pigmentosa GTPase Regulator (RPGR) mutations. Another algorithm will be developed to measure and monitor retinal changes over time...
Published Date: January 27, 2026
Published By: Franklin W. Lusby, MD, Ophthalmologist, Lusby Vision Institute, La Jolla, CA. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.
Cioffi GA, Liebmann JM. Diseases of the visual system. In: Goldman L, Cooney KA, eds. Goldman-Cecil Medicine. 27th ed. Philadelphia, PA: Elsevier; 2024:chap 391.
Colombo L, Baldesi J, Martella S, et al. Managing retinitis pigmentosa: A literature review of current non-surgical approaches. J Clin Med. 2025;14(2):330. PMID: 39860336 pubmed.ncbi.nlm.nih.gov/39860336/.
Cukras CA, Zein WM, Sieving PA. Progressive and 'stationary' inherited retinal degenerations. In: Yanoff M, Duker JS, eds. Ophthalmology. 6th ed. Philadelphia, PA: Elsevier; 2023:chap 6.12.
Olitisky SE, Marsh JD. Disorders of the retina and vitreous. In: Kliegman RM, St. Geme JW, Blum NJ, et al, eds. Nelson Textbook of Pediatrics. 22nd ed. Philadelphia, PA: Elsevier; 2025:chap 670.
Pennesi ME, Yang P, Gregory-Evans K. Retinitis pigmentosa and allied disorders. In: Sadda SR, Sarraf D, Freund KB, et al, eds. Ryan's Retina. 7th ed. Philadelphia, PA: Elsevier; 2023:chap 43.

